IMGN - ImmunoGen provides Q4 guidance
ImmunoGen (IMGN) expects to report ~$294M of cash and cash equivalents for the year ended December 31, 2020.Dive deeper into the company presentation.
For further details see:
ImmunoGen provides Q4 guidanceLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get IMGN Alerts
News, Short Squeeze, Breakout and More Instantly...